R. Berg

发表

Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.

J. Koropatnick, M. Vincent, T. Jason, 2006, Gene expression.

The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.

J. Koropatnick, R. Berg, Peter J Ferguso, 2002, Current drug targets.

Induction of systemic antitumor immunity by gene transfer of mammalian heat shock protein 70.1 into tumors in situ

G. Krissansen, K. Lisowska, K. Lehnert, 2001, Cancer Gene Therapy.

Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma

M. Fukushima, J. Koropatnick, M. Vincent, 2006, Molecular Cancer Therapeutics.

Combination Silencer RNA (siRNA) Targeting Bcl-2 Antagonizes siRNA against Thymidylate Synthase in Human Tumor Cell Lines

A. Pandyra, J. Koropatnick, M. Vincent, 2007, Journal of Pharmacology and Experimental Therapeutics.

ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.

J. Koropatnick, R. Figueredo, P. Ferguson, 2008, DNA and cell biology.

Toxicology of antisense therapeutics.

J. Koropatnick, T. Jason, R. Berg, 2004, Toxicology and applied pharmacology.

A “combination oligonucleotide” antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance

P. Ferguson, M. Vincent, R. Berg, 2003, Cancer Gene Therapy.

Pharmacokinetics of Nucleic‐Acid‐Based Therapeutics

A. Pandyra, J. C. Schmitz, J. Koropatnick, 2010 .

Cell density and cell cycle effects on retinoic acid-induced embryonal carcinoma cell differentiation.

M. McBurney, M W McBurney, R W Berg, 1990, Developmental biology.

Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.

P. Ferguson, M. Vincent, C. Postenka, 2001, The Journal of pharmacology and experimental therapeutics.

Cloning and Characterization of a Novel β Integrin-Related cDNA Coding for the Protein TIED (“Ten β Integrin EGF-like Repeat Domains”) That Maps to Chromosome Band 13q33: A Divergent Stand-Alone Integrin Stalk Structure

C. Morris, E. Leung, G. Krissansen, 1999 .

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.

G. Krissansen, R. Kanwar, J. Kanwar, 2001, Journal of the National Cancer Institute.